Fiji Kava names new CEO
In this article (5)
Health and wellness company Fiji Kava has appointed Dr. Anthony Noble as its new CEO effective May 31.
Noble is currently the MD and CEO of Australian Biotherapeutics and has experiences in natural product development, sales and operations management.
“Anthony’s experience and background in the natural products and biotechnology industries are directly transferable to Fiji Kava, including operational supply chain excellence and in growing the availability of our Fijian Noble Kava across key international markets with new and existing partners,” said Fiji Kava chairman, Dr. Andrew Kelly.
“We were extremely impressed by the success of Australian Biotherapeutics under the leadership of Anthony including the role he played in securing investment and commissioning their $10m greenfield production facility in Queensland.” Prior to Australian Biotherapeutics, Noble spent 10 years at SFI Health, SFI Research as global head of innovation, and head of North Asia, GM of the company’s Chinese joint venture, and global head of business to business.
Nicholas Simms, who has been acting as interim CEO, will continue as a non-executive director with founder Zane Yoshida on the Fiji Kava Board.
Questions & Answers
Q.When will Dr. Anthony Noble officially start his new role as CEO of Fiji Kava?
When will Dr. Anthony Noble officially start his new role as CEO of Fiji Kava?
Dr. Anthony Noble is set to begin his tenure as Fiji Kava's new Chief Executive Officer starting on May 31. This appointment marks a significant leadership change for the health and wellness company.
Q.What key experience does Fiji Kava's chairman highlight as valuable in the new CEO?
What key experience does Fiji Kava's chairman highlight as valuable in the new CEO?
Fiji Kava's chairman, Dr. Andrew Kelly, highlighted Dr. Noble's experience in natural products and biotechnology industries. This includes operational supply chain excellence and expanding the availability of Fijian Noble Kava internationally with partners.
Q.What was Dr. Anthony Noble's previous role before joining Fiji Kava?
What was Dr. Anthony Noble's previous role before joining Fiji Kava?
Before his appointment at Fiji Kava, Dr. Anthony Noble served as the Managing Director and CEO of Australian Biotherapeutics. He also spent a decade at SFI Health, SFI Research in various global and regional leadership positions.
Q.What role will Nicholas Simms take on after Dr. Noble becomes CEO?
What role will Nicholas Simms take on after Dr. Noble becomes CEO?
Nicholas Simms, who served as interim CEO, will remain with Fiji Kava as a non-executive director on the Board. He will continue to contribute alongside founder Zane Yoshida.
Reader pulse
Is this a strong appointment?
22,869 votes so far